Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility

Treatment options for influenza B virus infections are limited to neuraminidase inhibitors (NAIs), which block the neuraminidase (NA) glycoprotein on the virion surface. The development of NAI resistance would therefore result in a loss of antiviral treatment options for influenza B virus infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrukee, R., Zarebski, A. E., McCaw, J. M., Bloom, J. D., Reading, P. C., Hurt, A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201084/
https://www.ncbi.nlm.nih.gov/pubmed/30201817
http://dx.doi.org/10.1128/AAC.01081-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201084/
https://www.ncbi.nlm.nih.gov/pubmed/30201817
http://dx.doi.org/10.1128/AAC.01081-18

Ejemplares similares